title: Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease.
authors.affiliation: Department of Neuroscience, University Hospital, Uppsala, Sweden. joakim.tedroff@swipnet.se
authors.forename: J
authors.initials: J
authors.lastname: Tedroff
authors.forename: A
authors.initials: A
authors.lastname: Ekesbo
authors.forename: C
authors.initials: C
authors.lastname: Sonesson
authors.forename: N
authors.initials: N
authors.lastname: Waters
authors.forename: A
authors.initials: A
authors.lastname: Carlsson
mesh_terms: D018492:Dopamine Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D018492:Dopamine Antagonists; D010880:Piperidines; C109513:OSU 6162